First-in-human study of RAG-01: A novel small activating RNA therapeutic in BCG failure non-muscle invasive bladder cancer (NMIBC) patients. - KIVIRID

First-in-human study of RAG-01: A novel small activating RNA therapeutic in BCG failure non-muscle invasive bladder cancer (NMIBC) patients.

Authors: Laurence Krieger

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16587

Source: Full article

Abstract

e16587